In recent months, a concerning increase in product recalls related to bacterial contamination has hit the cosmetic industry. From popular mascara brands to specialty skin cleansers, these cosmetic industry Quality Control (QC) failures exposed consumers to the risk of infections. Understanding the causes of these contaminations and their solutions is important for QC professionals and manufacturers seeking to protect consumer safety while avoiding product recalls.
What Are Microbiological Contaminations?
Microbiological contamination happens when microorganisms infiltrate cosmetic products during manufacturing, storage, or consumer use. This issue is favored by these products’ formulations, which contain water, organic compounds, and minerals, creating a suitable environment for bacterial and fungal proliferation. A recent review published in Cosmetics reports that contamination affects products across different categories, with water-based formulations being particularly vulnerable.
Common bacterial contaminants include Pseudomonas aeruginosa, Staphylococcus aureus, and Burkholderia cepacia complex; these opportunistic pathogens pose a high risk, especially to immunocompromised individuals. Fungi such as Candida species and Aspergillus are also found in contaminated products, especially those used near mucous membranes or broken skin.
Regulatory bodies set strict limits. The European Medicines Agency bans the presence of certain microorganisms in finished cosmetics, including S. aureus and C. albicans, while FDA standards similarly specify acceptable microbial levels for various product categories. Significantly, products intended for use on damaged skin or near the eyes have stricter limits than those intended for use on intact skin.
A troubling six-month pattern: major recalls across product categories
Between September 2025 and March 2026, multiple recalls revealed systemic flaws in cosmetic manufacturing and distribution:
Neutrogena Makeup Remover Wipes – September 2025
Kenvue Brands initiated a voluntary recall after internal testing detected Pluralibacter gergoviae in one batch of their makeup remover wipes. P. gergoviae can cause urinary tract infections, respiratory issues, sepsis, and eye infections, especially in vulnerable groups. This preservative-resistant bacterium has been linked to over 1300 cases across the US, and the FDA classified this as Class II, meaning it may cause temporary or reversible health effects.
DermaRite Personal Care Products – August-September 2025
DermaRite Industries recalled dozens of products due to contamination with Burkholderia cepacia complex. These products included shampoos, body washes, and skin cleansers distributed in the US. B. cepacia can enter the bloodstream, causing sepsis, with some strains resisting standard antibiotics, which makes infections hard to treat.
Henkel Tec Italy Shampoo – March 2026
Henkel recalled over 1,000 shampoo units distributed in New York and California after detecting Klebsiella oxytoca. Again, this bacterium causes infections of the eyes, nose, and skin. The proactive recall occurred despite no reported injuries.
UK MHRA Hibiwash Recall – March 2026
Mölnlycke Health Care recalled three batches of Hibiwash antimicrobial skin cleanser after routine monitoring at the manufacturing facility detected B. cepacia. No reports of patient harm have emerged, but the precautionary action highlights regulatory vigilance.
These cases show that contamination happens more frequently than customers expect, occurring at various stages of the cosmetic life cycle: during formulation and manufacturing, through inadequate facility sanitation, via compromised raw materials, and during storage and distribution. Each failure point requires specific control measures.
Customer impact: from minor irritation to life-threatening infections
The risk posed by contaminated cosmetics depends on the organism involved and the individual’s vulnerabilities. The general population using contaminated products may experience mild skin irritation, localized redness, or contact dermatitis; these reactions usually resolve after stopping the use of the product. Eye cosmetics contaminated with Pseudomonas or other bacteria can cause keratitis, conjunctivitis, or more severe corneal infections, leading to possible permanent vision loss if treatment is delayed.
More serious outcomes are likely in immunocompromised individuals. Chemotherapy patients, organ transplant recipients, and those with HIV/AIDS face significantly higher infection risks. For these individuals, contaminated cosmetics can introduce bacteria into the bloodstream through minor skin cuts or contact with mucous membranes. Sepsis can develop quickly, necessitating hospitalization and aggressive antibiotic treatment.
Manufacturer impact: financial and reputational costs
Contamination events impose high costs on cosmetic manufacturers. Direct financial impacts include recall-related expenses and product destruction. For instance, the Neutrogena recall led to substantial product loss, while DermaRite’s expanded recall involved dozens of product lines distributed nationwide, increasing these costs.
These direct costs are just the beginning: reputational damage often outweighs immediate financial losses. Consumer trust diminishes when safety issues arise – especially for well-established brands known for dermatologist endorsements and safety assurances – and social media amplification further accelerates reputational damage.
Manufacturing disruptions accompany these recalls. Facilities must undergo thorough cleaning, equipment validation, and process reviews before resuming operations. Such operational pauses impact revenue, even as fixed costs remain constant.
Additionally, regulatory consequences follow contamination incidents. Agencies may tighten inspection schedules, require detailed corrective action plans, or impose consent decrees that restrict production until compliance is achieved.
Solutions and Risk Mitigation
Preventing microbiological contamination requires coordinated strategies involving facility design, process controls, staff empowerment, and quality assurance.
Environmental Controls
Manufacturing facilities require controlled environments with appropriate air quality, humidity, and temperature. Positive pressure prevents contaminants from moving between areas, and regular surface monitoring with swabs (such as Copan SRK) and air sampling ensures effective cleaning.
Since many cosmetics rely on water as a key ingredient, water systems need special care: water treatments must ensure microbiologically controlled water meets set standards, and regular testing for total viable count and specific pathogens guarantees quality.
Raw Material Controls
Incoming raw materials can be sources of contamination, so supplier qualification programs that verify material quality and ensure supplier compliance with GMP are essential. Some manufacturers even conduct independent testing of critical ingredients rather than relying solely on supplier data.
Preservative Systems
Effective preservation prevents microbial growth throughout the product’s shelf life and during consumer use. The choice of preservative depends on the product’s pH, formulation components, intended use, and regulatory restrictions. Using combinations of multiple agents can provide broader protection while reducing the amount of each preservative needed.
Process Design
Manufacturing processes should minimize contamination opportunities: closed systems to reduce environmental exposure, automated equipment to limit human contact with products, and proper equipment design to facilitate cleaning and prevent microbial harborage.
Personnel Training
Manufacturing personnel are both sources of contamination and key control points. Implementing training and retraining programs that teach staff about hygiene standards and proper aseptic techniques is essential. Of course, the correct use of DPI is fundamental.
Automated solutions for quality control: Newlab Cyclone
Microbiological testing is crucial for preventing and detecting contamination. However, traditional methods, which involve manual sample collection, transportation, and laboratory processing, can cause delays and errors that undermine the reliability of results.
Automated systems overcome these issues by offering standardized, reproducible sample processing. The Copan Newlab Cyclone exemplifies the most advanced solution of this type. It can handle multiple protocols in a single run using various-shaped containers, different inoculation volumes, sample mixing, dilution sets, and multiple types of agar. It performs all plating techniques, including spreading, pouring, and streaking. Additionally, communication with the LIMS enables automatic sample identification, protocol setting adjustments, and final report generation.
Its high scalability enables performance customization to meet any need – even during peak production – ensuring the safety of cosmetic products.
Conclusions
The recent wave of cosmetic recalls underscores that preventing contamination requires close attention at every stage of manufacturing. Effective programs combine environmental controls, validated processes, competent personnel, and robust testing, since single control-point failures can compromise consumer safety and cause substantial business damage.
Cosmetic manufacturers need to keep advancing their contamination prevention methods by investing in quality systems, workforce development, and modern testing technologies. This will yield benefits in reducing recalls, maintaining consumer trust, and gaining a competitive advantage in safety-focused markets.
For QC professionals considering contamination prevention strategies, the evidence supports an integrated approach. Automated testing equipment, such as the Copan Newlab Cyclone, complements but does not replace fundamental GMP principles. The combination of automated precision, robust process controls, and trained personnel creates the strong systems needed to prevent contamination failures seen in recent recalls.
Bibliography
- da Silva JD, Silva FAM, Rodrigues CF. Microbial Contamination in Cosmetic Products. Cosmetics. 2025; 12(5):198.
- https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts
- https://www.thehealthy.com/news/neutrogena-recall-october-2025/
- https://people.com/neutrogena-recalls-makeup-remover-ultra-soft-cleansing-towelettes-four-states-11837202
- https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/dermarite-industries-expands-voluntary-nationwide-recall-due-potential-burkholderia-cepacia
- https://www.globalcosmeticsnews.com/henkel-recalls-tec-italy-shampoo-over-bacterial-contamination/
- https://www.glasgowlive.co.uk/news/health/mhra-recalls-50000-skin-cleanser-33663068
Join CoScience HUB
Create your CoScience HUB account now to access cutting-edge science and position yourself at the forefront of innovation.
Sign Up Now
